Approach to asthma inhaler compliance using breath measurement of tetrafluoroethane
US9581586B2 · kind B2 · utility
1Cited by
4References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2015 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Aug 24, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/4975
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to measuring the effectiveness and an compliance of inhaler medication, such as for asthma treatment. In one embodiment, the invention provides a method of determining the effectiveness of an inhaler medication, comprising taking a measurement of HFA-134(a) from an exhaled breath of an individual after the individual has inhaled a medication, and determining an effective administration of the medication based on the presence of a high level of HFA-134(a).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.